glp 1 marketing GLP-1 Drug Market: the rapid growth of the diabetes and obesity drugs market GLP-1 Receptor Agonist Market Size

Wu J, et al

The results of once daily administration of the peptide for 12 weeks showed that it tripled weight loss when compared to placebo and the rate of weight loss remained steady

8, 2025 FAYETTEVILLE, Ark

Oral supplements are exposed to the hazards of stomach acid, digestive enzymes, food-related breakdown, first pass metabolism, and other bioavailability issues in the gastro-intestinal system

Antiobesity pharmacotherapy is intended for long-term use, as obesity is a chronic disease

However, these trials had relatively short follow-up periods and excluded patients at high risk for MTC, limiting the ability to detect rare events or long-term risks